Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indivior's Once-Monthly Buprenorphine Clears US FDA With Box Warning, REMS

Executive Summary

Launch targeted for first quarter 2018 at price of $1,580 per monthly dose. Post-market requirements include study of 300 mg dose and use as initial treatment. Indivior also following health outcomes.

Advertisement

Related Content

Keeping Track: US FDA Approvals For Tibsovo, Kisqali And Second Neupogen Biosimilar
Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction
Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction
Interview: C4XD Chief Sees Indivior Pact As First Of Many
Keeping Track: Shutdown Edition
Braeburn's Buprenorphine Bid: Eight Dosing Options Part Of "All Hands On Deck" Approach
Braeburn's Buprenorphine Clears Advisory Committee, But US FDA Likely To Limit Dosage
Indivior's Monthly Injectable Buprenorphine Wins Panel Backing; US FDA May Limit Dosage
Buprenorphine Injectable Opioid Abuse Treatment: Will REMS Prevent Misuse?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel